Click for best price
NSAIDs Market Size, Share 2024
This research report provides a comprehensive analysis of the NSAIDs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global NSAIDs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of NSAIDs, challenges faced by the industry, and potential opportunities for market players.
The global NSAIDs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The NSAIDs market presents opportunities for various stakeholders, including Back Pain Treatment, Osteoarthritis Treatment. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in NSAIDs market. Additionally, the growing consumer demand present avenues for market expansion.
The global NSAIDs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the NSAIDs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the NSAIDs market.
Market Overview: The report provides a comprehensive overview of the NSAIDs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Aspirin, Ibuprofen), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the NSAIDs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the NSAIDs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the NSAIDs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the NSAIDs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the NSAIDs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the NSAIDs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for NSAIDs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the NSAIDs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
NSAIDs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Market segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Global NSAIDs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Outline of Major Chapters:
Chapter 1: Introduces the definition of NSAIDs, market overview.
Chapter 2: Global NSAIDs market size in revenue and volume.
Chapter 3: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global NSAIDs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
NSAIDs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NSAIDs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSAIDs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSAIDs Overall Market Size
2.1 Global NSAIDs Market Size: 2023 VS 2030
2.2 Global NSAIDs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global NSAIDs Sales: 2019-2030
3 Company Landscape
3.1 Top NSAIDs Players in Global Market
3.2 Top Global NSAIDs Companies Ranked by Revenue
3.3 Global NSAIDs Revenue by Companies
3.4 Global NSAIDs Sales by Companies
3.5 Global NSAIDs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 NSAIDs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers NSAIDs Product Type
3.8 Tier 1, Tier 2 and Tier 3 NSAIDs Players in Global Market
3.8.1 List of Global Tier 1 NSAIDs Companies
3.8.2 List of Global Tier 2 and Tier 3 NSAIDs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global NSAIDs Market Size Markets, 2023 & 2030
4.1.2 Aspirin
4.1.3 Ibuprofen
4.1.4 Naproxen
4.1.5 Nabumetone
4.1.6 Others
4.2 By Type - Global NSAIDs Revenue & Forecasts
4.2.1 By Type - Global NSAIDs Revenue, 2019-2024
4.2.2 By Type - Global NSAIDs Revenue, 2025-2030
4.2.3 By Type - Global NSAIDs Revenue Market Share, 2019-2030
4.3 By Type - Global NSAIDs Sales & Forecasts
4.3.1 By Type - Global NSAIDs Sales, 2019-2024
4.3.2 By Type - Global NSAIDs Sales, 2025-2030
4.3.3 By Type - Global NSAIDs Sales Market Share, 2019-2030
4.4 By Type - Global NSAIDs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NSAIDs Market Size, 2023 & 2030
5.1.2 Back Pain Treatment
5.1.3 Osteoarthritis Treatment
5.1.4 Other Disease Treatment
5.2 By Application - Global NSAIDs Revenue & Forecasts
5.2.1 By Application - Global NSAIDs Revenue, 2019-2024
5.2.2 By Application - Global NSAIDs Revenue, 2025-2030
5.2.3 By Application - Global NSAIDs Revenue Market Share, 2019-2030
5.3 By Application - Global NSAIDs Sales & Forecasts
5.3.1 By Application - Global NSAIDs Sales, 2019-2024
5.3.2 By Application - Global NSAIDs Sales, 2025-2030
5.3.3 By Application - Global NSAIDs Sales Market Share, 2019-2030
5.4 By Application - Global NSAIDs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global NSAIDs Market Size, 2023 & 2030
6.2 By Region - Global NSAIDs Revenue & Forecasts
6.2.1 By Region - Global NSAIDs Revenue, 2019-2024
6.2.2 By Region - Global NSAIDs Revenue, 2025-2030
6.2.3 By Region - Global NSAIDs Revenue Market Share, 2019-2030
6.3 By Region - Global NSAIDs Sales & Forecasts
6.3.1 By Region - Global NSAIDs Sales, 2019-2024
6.3.2 By Region - Global NSAIDs Sales, 2025-2030
6.3.3 By Region - Global NSAIDs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America NSAIDs Revenue, 2019-2030
6.4.2 By Country - North America NSAIDs Sales, 2019-2030
6.4.3 US NSAIDs Market Size, 2019-2030
6.4.4 Canada NSAIDs Market Size, 2019-2030
6.4.5 Mexico NSAIDs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe NSAIDs Revenue, 2019-2030
6.5.2 By Country - Europe NSAIDs Sales, 2019-2030
6.5.3 Germany NSAIDs Market Size, 2019-2030
6.5.4 France NSAIDs Market Size, 2019-2030
6.5.5 U.K. NSAIDs Market Size, 2019-2030
6.5.6 Italy NSAIDs Market Size, 2019-2030
6.5.7 Russia NSAIDs Market Size, 2019-2030
6.5.8 Nordic Countries NSAIDs Market Size, 2019-2030
6.5.9 Benelux NSAIDs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia NSAIDs Revenue, 2019-2030
6.6.2 By Region - Asia NSAIDs Sales, 2019-2030
6.6.3 China NSAIDs Market Size, 2019-2030
6.6.4 Japan NSAIDs Market Size, 2019-2030
6.6.5 South Korea NSAIDs Market Size, 2019-2030
6.6.6 Southeast Asia NSAIDs Market Size, 2019-2030
6.6.7 India NSAIDs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America NSAIDs Revenue, 2019-2030
6.7.2 By Country - South America NSAIDs Sales, 2019-2030
6.7.3 Brazil NSAIDs Market Size, 2019-2030
6.7.4 Argentina NSAIDs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa NSAIDs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa NSAIDs Sales, 2019-2030
6.8.3 Turkey NSAIDs Market Size, 2019-2030
6.8.4 Israel NSAIDs Market Size, 2019-2030
6.8.5 Saudi Arabia NSAIDs Market Size, 2019-2030
6.8.6 UAE NSAIDs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer NSAIDs Major Product Offerings
7.1.4 Bayer NSAIDs Sales and Revenue in Global (2019-2024)
7.1.5 Bayer Key News & Latest Developments
7.2 Novacap
7.2.1 Novacap Company Summary
7.2.2 Novacap Business Overview
7.2.3 Novacap NSAIDs Major Product Offerings
7.2.4 Novacap NSAIDs Sales and Revenue in Global (2019-2024)
7.2.5 Novacap Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott NSAIDs Major Product Offerings
7.3.4 Abbott NSAIDs Sales and Revenue in Global (2019-2024)
7.3.5 Abbott Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer NSAIDs Major Product Offerings
7.4.4 Pfizer NSAIDs Sales and Revenue in Global (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson NSAIDs Major Product Offerings
7.5.4 Johnson & Johnson NSAIDs Sales and Revenue in Global (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Cigna
7.6.1 Cigna Company Summary
7.6.2 Cigna Business Overview
7.6.3 Cigna NSAIDs Major Product Offerings
7.6.4 Cigna NSAIDs Sales and Revenue in Global (2019-2024)
7.6.5 Cigna Key News & Latest Developments
7.7 Geri-Care Pharmaceuticals
7.7.1 Geri-Care Pharmaceuticals Company Summary
7.7.2 Geri-Care Pharmaceuticals Business Overview
7.7.3 Geri-Care Pharmaceuticals NSAIDs Major Product Offerings
7.7.4 Geri-Care Pharmaceuticals NSAIDs Sales and Revenue in Global (2019-2024)
7.7.5 Geri-Care Pharmaceuticals Key News & Latest Developments
7.8 Perrigo Company
7.8.1 Perrigo Company Company Summary
7.8.2 Perrigo Company Business Overview
7.8.3 Perrigo Company NSAIDs Major Product Offerings
7.8.4 Perrigo Company NSAIDs Sales and Revenue in Global (2019-2024)
7.8.5 Perrigo Company Key News & Latest Developments
7.9 Kopran
7.9.1 Kopran Company Summary
7.9.2 Kopran Business Overview
7.9.3 Kopran NSAIDs Major Product Offerings
7.9.4 Kopran NSAIDs Sales and Revenue in Global (2019-2024)
7.9.5 Kopran Key News & Latest Developments
7.10 Merck Sharp & Dohme
7.10.1 Merck Sharp & Dohme Company Summary
7.10.2 Merck Sharp & Dohme Business Overview
7.10.3 Merck Sharp & Dohme NSAIDs Major Product Offerings
7.10.4 Merck Sharp & Dohme NSAIDs Sales and Revenue in Global (2019-2024)
7.10.5 Merck Sharp & Dohme Key News & Latest Developments
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Company Summary
7.11.2 Sun Pharmaceutical Industries Business Overview
7.11.3 Sun Pharmaceutical Industries NSAIDs Major Product Offerings
7.11.4 Sun Pharmaceutical Industries NSAIDs Sales and Revenue in Global (2019-2024)
7.11.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Summary
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline NSAIDs Major Product Offerings
7.12.4 GlaxoSmithKline NSAIDs Sales and Revenue in Global (2019-2024)
7.12.5 GlaxoSmithKline Key News & Latest Developments
7.13 Reddy Pharmaceuticals
7.13.1 Reddy Pharmaceuticals Company Summary
7.13.2 Reddy Pharmaceuticals Business Overview
7.13.3 Reddy Pharmaceuticals NSAIDs Major Product Offerings
7.13.4 Reddy Pharmaceuticals NSAIDs Sales and Revenue in Global (2019-2024)
7.13.5 Reddy Pharmaceuticals Key News & Latest Developments
7.14 Verywell
7.14.1 Verywell Company Summary
7.14.2 Verywell Business Overview
7.14.3 Verywell NSAIDs Major Product Offerings
7.14.4 Verywell NSAIDs Sales and Revenue in Global (2019-2024)
7.14.5 Verywell Key News & Latest Developments
8 Global NSAIDs Production Capacity, Analysis
8.1 Global NSAIDs Production Capacity, 2019-2030
8.2 NSAIDs Production Capacity of Key Manufacturers in Global Market
8.3 Global NSAIDs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NSAIDs Supply Chain Analysis
10.1 NSAIDs Industry Value Chain
10.2 NSAIDs Upstream Market
10.3 NSAIDs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 NSAIDs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of NSAIDs in Global Market
Table 2. Top NSAIDs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global NSAIDs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global NSAIDs Revenue Share by Companies, 2019-2024
Table 5. Global NSAIDs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global NSAIDs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers NSAIDs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers NSAIDs Product Type
Table 9. List of Global Tier 1 NSAIDs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NSAIDs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global NSAIDs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global NSAIDs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global NSAIDs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global NSAIDs Sales (K Pcs), 2019-2024
Table 15. By Type - Global NSAIDs Sales (K Pcs), 2025-2030
Table 16. By Application ? Global NSAIDs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global NSAIDs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global NSAIDs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global NSAIDs Sales (K Pcs), 2019-2024
Table 20. By Application - Global NSAIDs Sales (K Pcs), 2025-2030
Table 21. By Region ? Global NSAIDs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global NSAIDs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global NSAIDs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global NSAIDs Sales (K Pcs), 2019-2024
Table 25. By Region - Global NSAIDs Sales (K Pcs), 2025-2030
Table 26. By Country - North America NSAIDs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America NSAIDs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America NSAIDs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America NSAIDs Sales, (K Pcs), 2025-2030
Table 30. By Country - Europe NSAIDs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe NSAIDs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe NSAIDs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe NSAIDs Sales, (K Pcs), 2025-2030
Table 34. By Region - Asia NSAIDs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia NSAIDs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia NSAIDs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia NSAIDs Sales, (K Pcs), 2025-2030
Table 38. By Country - South America NSAIDs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America NSAIDs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America NSAIDs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America NSAIDs Sales, (K Pcs), 2025-2030
Table 42. By Country - Middle East & Africa NSAIDs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa NSAIDs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa NSAIDs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa NSAIDs Sales, (K Pcs), 2025-2030
Table 46. Bayer Company Summary
Table 47. Bayer NSAIDs Product Offerings
Table 48. Bayer NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Bayer Key News & Latest Developments
Table 50. Novacap Company Summary
Table 51. Novacap NSAIDs Product Offerings
Table 52. Novacap NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. Novacap Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott NSAIDs Product Offerings
Table 56. Abbott NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. Abbott Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer NSAIDs Product Offerings
Table 60. Pfizer NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson NSAIDs Product Offerings
Table 64. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Cigna Company Summary
Table 67. Cigna NSAIDs Product Offerings
Table 68. Cigna NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Cigna Key News & Latest Developments
Table 70. Geri-Care Pharmaceuticals Company Summary
Table 71. Geri-Care Pharmaceuticals NSAIDs Product Offerings
Table 72. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. Geri-Care Pharmaceuticals Key News & Latest Developments
Table 74. Perrigo Company Company Summary
Table 75. Perrigo Company NSAIDs Product Offerings
Table 76. Perrigo Company NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Perrigo Company Key News & Latest Developments
Table 78. Kopran Company Summary
Table 79. Kopran NSAIDs Product Offerings
Table 80. Kopran NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Kopran Key News & Latest Developments
Table 82. Merck Sharp & Dohme Company Summary
Table 83. Merck Sharp & Dohme NSAIDs Product Offerings
Table 84. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Merck Sharp & Dohme Key News & Latest Developments
Table 86. Sun Pharmaceutical Industries Company Summary
Table 87. Sun Pharmaceutical Industries NSAIDs Product Offerings
Table 88. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. Sun Pharmaceutical Industries Key News & Latest Developments
Table 90. GlaxoSmithKline Company Summary
Table 91. GlaxoSmithKline NSAIDs Product Offerings
Table 92. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. GlaxoSmithKline Key News & Latest Developments
Table 94. Reddy Pharmaceuticals Company Summary
Table 95. Reddy Pharmaceuticals NSAIDs Product Offerings
Table 96. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 97. Reddy Pharmaceuticals Key News & Latest Developments
Table 98. Verywell Company Summary
Table 99. Verywell NSAIDs Product Offerings
Table 100. Verywell NSAIDs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 101. Verywell Key News & Latest Developments
Table 102. NSAIDs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2022-2024 (K Pcs)
Table 103. Global NSAIDs Capacity Market Share of Key Manufacturers, 2022-2024
Table 104. Global NSAIDs Production by Region, 2019-2024 (K Pcs)
Table 105. Global NSAIDs Production by Region, 2025-2030 (K Pcs)
Table 106. NSAIDs Market Opportunities & Trends in Global Market
Table 107. NSAIDs Market Drivers in Global Market
Table 108. NSAIDs Market Restraints in Global Market
Table 109. NSAIDs Raw Materials
Table 110. NSAIDs Raw Materials Suppliers in Global Market
Table 111. Typical NSAIDs Downstream
Table 112. NSAIDs Downstream Clients in Global Market
Table 113. NSAIDs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. NSAIDs Segment by Type in 2023
Figure 2. NSAIDs Segment by Application in 2023
Figure 3. Global NSAIDs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global NSAIDs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global NSAIDs Revenue, 2019-2030 (US$, Mn)
Figure 7. NSAIDs Sales in Global Market: 2019-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by NSAIDs Revenue in 2023
Figure 9. By Type - Global NSAIDs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global NSAIDs Revenue Market Share, 2019-2030
Figure 11. By Type - Global NSAIDs Sales Market Share, 2019-2030
Figure 12. By Type - Global NSAIDs Price (USD/Pcs), 2019-2030
Figure 13. By Application - Global NSAIDs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global NSAIDs Revenue Market Share, 2019-2030
Figure 15. By Application - Global NSAIDs Sales Market Share, 2019-2030
Figure 16. By Application - Global NSAIDs Price (USD/Pcs), 2019-2030
Figure 17. By Region - Global NSAIDs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global NSAIDs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global NSAIDs Revenue Market Share, 2019-2030
Figure 20. By Region - Global NSAIDs Sales Market Share, 2019-2030
Figure 21. By Country - North America NSAIDs Revenue Market Share, 2019-2030
Figure 22. By Country - North America NSAIDs Sales Market Share, 2019-2030
Figure 23. US NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe NSAIDs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe NSAIDs Sales Market Share, 2019-2030
Figure 28. Germany NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 29. France NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia NSAIDs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia NSAIDs Sales Market Share, 2019-2030
Figure 37. China NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 41. India NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America NSAIDs Revenue Market Share, 2019-2030
Figure 43. By Country - South America NSAIDs Sales Market Share, 2019-2030
Figure 44. Brazil NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa NSAIDs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa NSAIDs Sales Market Share, 2019-2030
Figure 48. Turkey NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE NSAIDs Revenue, (US$, Mn), 2019-2030
Figure 52. Global NSAIDs Production Capacity (K Pcs), 2019-2030
Figure 53. The Percentage of Production NSAIDs by Region, 2023 VS 2030
Figure 54. NSAIDs Industry Value Chain
Figure 55. Marketing Channels
